CAMBRIDGE, MASSACHUSETTS, November 2, 2007 – Today's issue of Mass High Tech highlights IntelligentMD in a front-page feature story about how IMD can improve the detection of deadly, difficult-to-diagnose superbugs.
The reputable journal, which covers the latest developments in New England technology, reports how IntellignetMD's assay development process could lead to the first rapid, sensitive and specific test for these antibiotic-resistant Staph. The emergence of superbugs in the national media has propelled IntelligentMD into the spotlight with the article calling IntelligentMD a life sciences firm "advancing new weapons to do battle against the lethal bacteria."
Click here to read the article.